Form 4: RenaissanceRe CFO Sells $1.5M in Stock Under 10b5-1 Plan
Insider Trading Report
RenaissanceRe Holdings Ltd.'s EVP and CFO, Robert Qutub, sold 5,000 shares of common stock for approximately $1.53 million through a pre-arranged trading plan.
Summary
- Robert Qutub, Executive Vice President and Chief Financial Officer of RenaissanceRe Holdings Ltd. (RNR), sold a total of 5,000 shares of the company's common stock.
- The transactions occurred on February 6, 2026.
- The sales were executed under a Rule 10b5-1 pre-arranged trading plan.
- The first sale involved 2,284 shares at a weighted average price of $305.422 per share, with prices ranging from $304.73 to $305.725.
- The second sale involved 2,716 shares at a weighted average price of $306.0283 per share, with prices ranging from $305.73 to $306.605.
- Following these transactions, Mr. Qutub beneficially owns 73,023 shares of RenaissanceRe common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces executive ownership, the execution under a Rule 10b5-1 plan suggests a pre-planned liquidity event rather than a reaction to new, negative company developments.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to new, non-public information.
Negatives
- An insider sale, even under a 10b5-1 plan, reduces the executive's direct equity stake in the company.
- The sale of 5,000 shares represents a significant value of approximately $1.53 million.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, particularly sales, are closely watched by the market as they can sometimes signal management's perception of future company performance. However, sales executed under a Rule 10b5-1 plan, as in this case, are pre-scheduled and generally viewed as less indicative of immediate sentiment compared to open-market discretionary sales. RenaissanceRe operates in the reinsurance sector, where executive compensation often includes significant equity components, making such planned sales a common part of personal financial management.
Comparison to Industry Standards
- StockSavvy.ai observes that planned insider sales are a common practice across industries, particularly for executives managing diversified portfolios and liquidity needs.
- For example, similar 10b5-1 plan sales have been observed at peer companies in the insurance and reinsurance sector, such as Chubb Limited (CB) or Everest Re Group, Ltd. (ERIE), where executives periodically monetize portions of their equity holdings.
- The volume and value of this transaction are within typical ranges for a CFO at a company of RenaissanceRe's market capitalization, not signaling an unusual or aggressive divestment compared to broader market trends for executive compensation and liquidity management.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a slight negative signal, though mitigated by the 10b5-1 plan.
- Management: The CFO is managing personal liquidity and diversifying assets, a common practice for executives.
Key Dates
| Date | Description |
|---|---|
| 2025-07-30 | Date of Power of Attorney execution by Robert Qutub. |
| 2026-02-06 | Date of common stock sales by Robert Qutub. |
Recommendation
holdThe insider sale by the CFO, while reducing his direct equity stake, was executed under a pre-arranged 10b5-1 plan. This suggests a planned liquidity event rather than a reaction to new, adverse company information. Therefore, this transaction alone does not provide a strong signal for a 'buy' or 'sell' recommendation, and a 'hold' stance is appropriate pending further fundamental analysis of RenaissanceRe's business performance and market conditions.
Keywords
RenaissanceRe Holdings Ltd, RNR, Robert Qutub, insider trading, stock sale, Form 4, SEC filing, CFO, 10b5-1 plan, equity transaction, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.